ArsenalBio Announces Presentation of Six Abstracts at AACR A

ArsenalBio Announces Presentation of Six Abstracts at AACR Annual Meeting Highlighting Programmable

Company to share preclinical data on the use of integrated circuit T cells for the development of cell therapies for the treatment of kidney and other solid tumor cancersSOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--#AACR23--Arsenal Biosciences, Inc. (ArsenalBio), a clinical stage programmable cell therapy company e...

Related Keywords

United States , American , Gwen Gordon , Ken Drazan , Arsenal Biosciences Inc , Linkedin , American Association For Cancer Research , Arsenalbio Co , Facebook , Arsenal Biosciences , American Association , Cancer Research , Chief Executive , Breaking Research , Adoptive Cell , Natural Killer Cell , Synthetic Pathway Activators , Lead Identification , Silico Drug , South San Francisco ,

© 2025 Vimarsana